.
MergerLinks Header Logo

New Deal


Announced

Nestlé Health Science to acquire PronoKal from Abac Capital.

Synopsis

Nestlé Health Science, a nutritional science firm, agreed to acquire PronoKal, a provider of weight loss and weight management services, from Abac Capital, a private equity firm. Financial terms were not disclosed. "Figuring out a healthy way to lose weight and to stick to the program can be daunting. With medical supervision, healthy ketogenic meals and always-on support through the app, PronoKal is designed to take the confusion and stress out of weight loss, supporting people through their weight management journey. The acquisition of PronoKal adds a new dimension to our weight management portfolio and will enable us to help more people lead healthier lives," Greg Behar, Nestlé Health Science CEO.

Show Details & Financials

Market Context

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US